Pmv Pharmaceuticals (PMVP) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Ladenburg Thalmann | Initiated Coverage | Buy | $3.00 | Jul 8, 2026 |
| Oppenheimer | Maintained | Outperform | $5.00 from $6.00 | May 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Mar 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Aug 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 30, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 14, 2024 |
| Craig-Hallum | Initiated Coverage | Buy | $6.00 | May 13, 2024 |
| Jefferies | Initiated Coverage | Buy | $5.00 | Apr 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Mar 7, 2024 |
| Ladenburg Thalmann | Initiated Coverage | Buy | $7.00 | Dec 27, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $29.00 | Oct 16, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $29.00 from $35.00 | Aug 11, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $35.00 | May 17, 2023 |
| Oppenheimer | Maintained | Outperform | $15.00 | May 11, 2023 |
Frequently asked questions
Is PMVP a buy, sell, or hold?
Analysts covering Pmv Pharmaceuticals currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on PMVP?
On Jul 8, 2026, Ladenburg Thalmann initiated coverage of Pmv Pharmaceuticals at Buy with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.